The discovery of new medicines often takes place in North America, Europe and Asia. So that's where the agenda tends to be ...

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience.

Berkshire County communities have spent hundreds of millions of dollars rebuilding aging schools since 2010, with projects in ...

Is RUSHA a good stock to buy? We came across a bullish thesis on Rush Enterprises, Inc. on Valueinvestorsclub.com by ...

The Daily Sun ran an article about the operator of an open-patio bar suing the city. The Southside Tavern operator alleges ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.

We strongly urge the U.S. Forest Service (with its reduced workforce) and fire departments in the area, with the support of ...

Strong Buy on 2025 sales growth, pipeline acquisitions like Synnovation, and drivers offsetting 2026 patent cliffs—read more ...

With cooking becoming difficult in the absence of steady gas supply, a homegrown solution is gaining traction — the ...

A new study published in Translational Psychiatry suggests that miniature, lab-grown brain models can reveal distinct electrical activity patterns in different types of autism. By analyzing brain ...

Royalty Pharma’s updated fair value price target now sits at US$51.56, compared with the previous US$51.00 level. Analysts linking this shift to current Street commentary point to optimism around the ...